The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of a STK11/KEAP1-mutation gene expression signature in lung adenocarcinoma with immune desertion in squamous cell carcinomas and mediation by NFE2L2 deregulation.
 
Damian Tobias Rieke
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alacris Theranostics; Bayer
 
Konrad Friedrich Klinghammer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology
 
Benedikt Obermayer
No Relationships to Disclose
 
Eric Blanc
No Relationships to Disclose
 
Clemens Messerschmidt
No Relationships to Disclose
 
Korinna Jöhrens
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - MSD; Roche
 
Frederick Klauschen
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Inge Tinhofer
Honoraria - Merck KGaA
Consulting or Advisory Role - Merck Serono
 
Dieter Beule
Stock and Other Ownership Interests - MicroDiscovery
Patents, Royalties, Other Intellectual Property - Ep2781910; US20140286550
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; MSD Oncology; Pierre Fabre
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; CureVac; Janssen-Cilag; Merck Serono; MSD
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Ipsen; Merck Serono